| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |